SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-03-016390
Filing Date
2003-08-01
Accepted
2003-08-01 10:40:47
Documents
4
Period of Report
2003-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a03-1698_110q.htm 10-Q 451998
3 EX-31.1 a03-1698_1ex311.htm EX-31.1 11215
4 EX-31.2 a03-1698_1ex312.htm EX-31.2 11830
5 EX-32.1 a03-1698_1ex321.htm EX-32.1 7410
  Complete submission text file 0001104659-03-016390.txt   484364
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15006 | Film No.: 03816618
SIC: 2835 In Vitro & In Vivo Diagnostic Substances